Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · operational-macro

FDA Approves Haemonetics' PerQseal Elite For Large-Bore Arterial Procedures

20 October 2026 · By · Wire by Fusion42

Published

20 October 2026

Topic

operational-macro

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at rttnews.com →

◆ Verified

Fusion42 · 20 October 2026 · Fusion42 review

The FDA has approved Haemonetics' PerQseal Elite device, designed for large-bore arterial procedures, marking a regulatory milestone for the company in the medical device sector.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

Your Medtech product line just gained clearance for a critical vascular procedure. This opens direct market access to hospitals requiring large-bore arterial devices.

◆ Coverage

1 source · 20 Oct 2026

◆ Related on Wire

◆ Topics

Medtechfda-approvalmedical-devicearterial-proceduresregulatory